Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
A2 Biotherapeutics Inc.
Novartis
NeoTX Therapeutics Ltd.
Nurix Therapeutics, Inc.
TCR2 Therapeutics
Incyte Corporation
Numab Therapeutics AG
NuCana plc
A2 Biotherapeutics Inc.
Medicenna Therapeutics, Inc.